HEB, Hemispherx Biopharma (AMEX)NEW Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HEB, Hemispherx Biopharma (AMEX)NEW

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: drkaz	2/11/2015 10:19:16 AM
	of 857

Diligence and Valuation Report Arrowhead Code: 69-03-01 Coverage initiated: 06 November 2014 This document: 08 January 2015 Fair share value bracket – DCF $1.67 - $2.79 Share price 07 Jan. 2015: $0.23i abid.co A report posted elsewhere (iHub) by Arrowhead Business and Investment Decisions - with Kudos to the original poster on iHub who goes by the handle there of LCRG6215 The report is a good read - and although it just might be a bit optimistic - it illustrates the potential here IF the company can continue to move forward.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next